Ophthalmology

Life science tool providers provide constant support to ever-evolving stem cell research community

The Sherley v. Sebelius lawsuit was dismissed by a federal judge after an appeals court found the government-backed research is probably lawful. In a related move, lawmakers in Congress have reintroduced legislation to support hESC research.

KalVista Pharmaceuticals, a new Southampton, United Kingdom-based ophthalmology company, has closed a Series A financing round that netted the company £8 million (approximately $13.2 million) from leading investors Novo A/S and SV Life Sciences.

MingSight, Relin form joint venture in China to develop novel treatment for diabetic eye disease

Isn’t it about time Congress revisited what is essentially an afterthought on a 15-year-old appropriations bill, clearly articulated the facts and concerns about hESC research and put forth a specific policy on the matter?

Allergan, Inc. is gaining another foothold in the field of dermatology thanks to its most recent acquisition.

Tufts researchers find protein CD59 is key to slowing age-related macular degeneration

Under a definitive merger agreement, Merck will acquire Inspire Pharmaceuticals Inc., a pharmaceutical company that focuses on the development and commercialization of ophthalmic products

Advanced Cell Technology and Roslin Cells announce agreement for storage and worldwide distribution of embryonic stem cells using ACT’s blastomere technology

Merck Serono to develop Domain Therapeutics’ mGluR4 allosteric modulators

RXi Pharmaceuticals and EyeGate Pharma see a future together focused on retinal therapies

AstraZeneca & UCL collaborate on stem cell solution to diabetic vision loss